Warren Buffett Bought 4 Pharma Giants in Q3
Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) filed its Form 13F with the Securities and Exchange Commission on Monday, which gave investors a look at what the Oracle of Omaha and his team of investors bought in the third quarter.
Among the list were four pharmaceutical companies: AbbVie (NYSE: ABBV), Merck (NYSE: MRK), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). The first three were similarly sized purchase of around $1.8 billion. The Pfizer purchase was substantially smaller, with a market value around $136 million.
Image source: The Motley Fool.
Source Fool.com
